![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Sunday, July 21, 2013 7:29:06 PM
As I have done every Sunday for as long as I can remember, I evaluate my portfolio and see what I have done well, where I have come up short and what I can do better to improve my returns. I have never posted on a message board and never even thought about investing in an IP type stock until DSS. What has been of particular interest to me has been the true lack of understanding of the machinations of most stocks and the due diligence required to make an informed decision. There are many here that do not post but have asked for various information from me that I generally will research and then post on the board. I am fortunate enough to be retired and have the time doing something I enjoy. I try not to rehash endlessly subjects that have been covered over the several months, and much longer quite honestly. I would just like to re-iterate what I think is important here.
What has been interesting to me is that DSS the company is in a very strange place regarding the investment community. I am sure that it is thrown into the “IP” type sector because they do pursue litigation and licensing. Not comparing companies in any way but so does QCOM, AAPL, GOOG, MSFT and others. I watch with interest through other IP plays that are currently in litigation and hanging on to every possible breeze that may blow with a potential “game changing” decision in the court. I am sure for those familiar with many of the briefings and announcements by DSS they do not want to be a company that hinges on one legal case to decide whether they are a viable company or not. If anyone is concerned, I assure you over the past few months the company has been very accessible and willing to discuss any topic as long as it wasn't involving a legal process. As a matter of fact you might be surprised with whom you may find yourself on the phone with. If you are new to investing, persistence, diligence and integrity are what you should build your foundation on. I would suggest if you are new to DSS that you research more than litigation related info, for example:
http://finance.yahoo.com/news/document-security-systems-readies-beta-120000291.html
They have been working with two Fortune 500 Pharmaceutical companies and their software is proprietary.
In regards to Bascom research, here is one link to remind you what the new DSS owns. Coincidentally it seems to fit right in with the DSS authentiguard product line IMO.
http://www.virtual-strategy.com/2012/09/20/lexington-technology-group-announces-closing-11-million-financing-and-sponsored-research-
Although we currently own only 7% stake in Virtual Agility, it was stated prior by company that they have the opportunity for future
investment (ownership piece) of Virtual Agility.
http://virtualagility.com/6701.html
My guess is that as litigations become more costly they will probably need help financially.
So it would seem on this Sunday night while I am looking at my DSS investment that “I” have made is a good investment. Now the purists in the IP sector may not consider this as important as I do. I am not unlike them and will trade this stock as many times as I can to make a profit and stockpile free shares. However, I do rest easy at night knowing my investment is in a real company, with real revenue and real possibilities. The company IMO will release some small blurb regarding the Novell settlement and some will argue perhaps the RR% was too small and others will say it foretells the FB percentage. For me it just adds value to the licensing/digital section of the financial filings. Good luck to all.
Recent DSS News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/09/2024 09:15:31 PM
- Impact Biomedical, Inc. Announces U.S. Patent Allowance of Laetose™ Technology Entitled "Low Glycemic Sugar Composition." • GlobeNewswire Inc. • 01/30/2024 01:05:56 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/22/2024 09:54:48 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/08/2024 09:05:40 PM
- DSS, Inc. Chairman Chan Acquires 672,173 shares of DSS In Open Market • GlobeNewswire Inc. • 01/04/2024 01:15:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2024 09:15:33 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/02/2024 02:10:36 PM
- DSS, Inc. Announces Reverse Split as Part of NYSE American Compliance Plan • GlobeNewswire Inc. • 12/22/2023 09:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/18/2023 09:30:23 PM
- Form DEF 14C - Other definitive information statements • Edgar (US Regulatory) • 12/13/2023 09:15:25 PM
- Form PRE 14C - Other preliminary information statements • Edgar (US Regulatory) • 12/01/2023 09:15:06 PM
- Premier Packaging, a Wholly-Owned Subsidiary of DSS, Inc., Secures Contract Extension with Major Retailer Worth Up to $15 Million over Four Years • GlobeNewswire Inc. • 11/28/2023 01:10:00 PM
- DSS Inc. Wins Patent Dispute with Nichia Corporation • GlobeNewswire Inc. • 11/14/2023 01:00:00 PM
- DSS, Inc. Subsidiary Files Current Report on Form 8-K Disclosing Reverse Split of Outstanding and Issued Common Stock and Conversion of Certain Holder’s Common Stock • GlobeNewswire Inc. • 11/08/2023 01:31:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/27/2023 08:05:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/26/2023 09:25:10 PM
- DSS Inc. Receives Notice of Non-Compliance with NYSE American Trading Share Price Listing Rule • GlobeNewswire Inc. • 10/26/2023 09:25:00 PM
- DSS, Inc. Announces Filing of Registration Statement on Form S-1 for Initial Public Offering of Impact Biomedical • GlobeNewswire Inc. • 10/23/2023 12:25:00 PM
- DSS Inc. Issues Letter to Shareholders • GlobeNewswire Inc. • 10/12/2023 12:25:00 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 10/03/2023 08:31:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/03/2023 08:30:13 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 09/12/2023 08:30:20 PM
- DSS Inc. Expands DSS Wealth Management, Inc.'s Management Team for Ramp Up of Asset Management Subsidiary • GlobeNewswire Inc. • 09/06/2023 12:40:00 PM
- DSS Inc. Announces Distribution Date of August 8, 2023 for Spinoff of Impact BioMedical Inc. • GlobeNewswire Inc. • 07/31/2023 12:15:00 PM
- DSS Inc. Appoints Daniel Lew as Chief Investment Officer and Portfolio Manager for DSS Wealth, Inc. • GlobeNewswire Inc. • 07/05/2023 12:15:00 PM
North Bay Resources Announces Composite Assays of 0.53 and 0.44 Troy Ounces per Ton Gold in Trenches B + C at Fran Gold, British Columbia • NBRI • Jun 18, 2024 9:18 AM
VAYK Assembling New Management Team for $64 Billion Domestic Market • VAYK • Jun 18, 2024 9:00 AM
Fifty 1 Labs, Inc Announces Acquisition of Drago Knives, LLC • CAFI • Jun 18, 2024 8:45 AM
Hydromer Announces Attainment of ISO 13485 Certification • HYDI • Jun 17, 2024 9:22 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • CAFI • Jun 13, 2024 8:45 AM